iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
210.82
+1.77 (0.85%)
At close: Sep 1, 2026, 4:00 PM EDT
211.16
+0.34 (0.16%)
After-hours: Sep 1, 2026, 7:56 PM EDT
IBB Holdings Information
IBB is an equity ETF with a total of 252 individual holdings. The top holdings are Amgen stock at 8.53%, Vertex Pharmaceuticals at 8.04%, Gilead Sciences at 7.20%, Regeneron Pharmaceuticals at 5.70%, and argenx SE at 3.78%.
Total Holdings
252
Top 10 Percentage
47.38%
Asset Class
Equity
ETF Category
Health
Assets
10.52B
PE Ratio
26.13
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | AMGN | Amgen Inc. | 8.53% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 8.04% |
| 3 | GILD | Gilead Sciences, Inc. | 7.20% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.70% |
| 5 | ARGX | argenx SE | 3.78% |
| 6 | MRNA | Moderna, Inc. | 3.57% |
| 7 | NTRA | Natera, Inc. | 3.17% |
| 8 | RVMD | Revolution Medicines, Inc. | 2.82% |
| 9 | ILMN | Illumina, Inc. | 2.31% |
| 10 | BIIB | Biogen Inc. | 2.27% |
| 11 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.24% |
| 12 | ONC | BeOne Medicines AG | 2.08% |
| 13 | INSM | Insmed Incorporated | 1.81% |
| 14 | INCY | Incyte Corporation | 1.75% |
| 15 | UTHR | United Therapeutics Corporation | 1.50% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.27% |
| 17 | GMAB | Genmab A/S | 1.23% |
| 18 | ASND | Ascendis Pharma A/S | 1.09% |
| 19 | NBIX | Neurocrine Biosciences, Inc. | 1.08% |
| 20 | CRL | Charles River Laboratories International, Inc. | 0.99% |
| 21 | MEDP | Medpace Holdings, Inc. | 0.98% |
| 22 | EXEL | Exelixis, Inc. | 0.94% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 0.92% |
| 24 | HALO | Halozyme Therapeutics, Inc. | 0.88% |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 0.88% |
As of Aug 28, 2026